18%

of FDA-approved small molecule drugs since 2014 have collaborated with us

200+

active Drug Master Files (DMFs) to date

2,500+

completed solid form projects across a range of structurally diverse and complex APIs

Advancing Science with You

Discover new ways to advance your science with Veranova. Our capabilities span a wide range of development technologies and specialties—all backed by comprehensive industry knowledge and experience.

Development

Extensive capabilities across both process and analytical development.

Technology

Tech capabilities that encompass solid form sciences including crystallization development and particle engineering.

Specialty

Specialty capabilities include highly potent APIs and drug linkers in addition to complex small molecule chemistry.

Supporting your Innovation with Collaboration

Whether you need a partner in development or an experienced leader to navigate complex scale-up, Veranova can help. Our deep knowledge of API manufacturing and processes is supported by a collaborative, consultative approach to ensure your expectations and milestones are met.

Discovery

With deep technical expertise and impressive flexibility, we help develop solutions and processes that support innovation.

Development and small-scale manufacturing

To support clinical trials, we establish manufacturing processes and analytical methods that are scalable and collaborative.

Large-scale manufacturing

We efficiently manage manufacturing APIs in commercial quantities with our agile network and supply chain.

Reformulation

We help you optimize your manufacturing processes and scale-up your services with confidence, speed and flexibility.

Our Values in Action

From reducing our environmental footprint and ensuring the highest standards of product safety to upholding ethical practices and promoting inclusion, our commitment to growth, environmental sustainability and responsible innovation is core to achieving our mission and creating long-term value.

Learn more about our corporate responsibility strategy
Trees with a cut out area depicting a pill

Featured insights from our experts

Read more

Nanomilling: A Key Technology for Enhancing Drug Delivery

Nanomilling is a particle-size reduction technique that can enhance the dissolution rate of poorly soluble active pharmaceutical ingredients (APIs) and therefore their bioavailability. This technology can also open opportunities for novel formulations.

Analytical Challenges for Antibody-Drug Conjugate (ADC) Manufacturing

Read our latest eBook that explores the critical challenges shaping ADC development today, from analytical strategy and impurity control to linker technology innovations and evolving regulatory standards. It also examines the collaborative expertise needed to bring these transformative therapies to patients.

Review of the FDA Draft Guidance on AI in Drug Development

In this article, Kishore Vatsavai, Principal Scientist, outlines the key takeaways from the FDA’s draft guidance, offers real-world examples of how AI is being applied in drug development today, and shares strategies to help mitigate bias and model drift, along with practical resources for those interested in learning more.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us